Criticare Life Sciences Private Limited
About Criticare Life Sciences Private Limited
Data last updated:
Criticare Life Sciences Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 06 August 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85190MH2008PTC185542.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kiran Santosh Rathi and Santosh Mohanlal Rathi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Between Hotel Royal Challenge II & Cadbury'S Ltd Eastern Express Highway(Service Road), Thane, Maharashtra, India – 400602.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹16.2 Lakh (net margin 14.6%) and EBITDA of ₹22.64 Lakh (EBITDA margin 20.4%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Criticare Life Sciences Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressBetween Hotel Royal Challenge II & Cadbury'S Ltd Eastern Express Highway(Service Road), Thane, Maharashtra, India – 400602
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Criticare Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Criticare Life Sciences is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Criticare Life Sciences Private Limited, buy the company report.
Financials of Criticare Life Sciences Private Limited
FY 2025 filings availableCriticare Life Sciences Private Limited reported revenue of ₹1.11 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 6% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.4% | ||||
| Net Profit Margin | 14.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Criticare Life Sciences Private Limited, buy the company report.
Board of directors of Criticare Life Sciences Private Limited
Criticare Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Santosh Rathi | Director | 06 Aug 2008 | 18 Years 2 Months | Current |
| Santosh Mohanlal Rathi | Director | 06 Aug 2008 | 18 Years 2 Months | Current |
Peer comparison
Criticare Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ajey Diagnostics Private Limited | ₹1.12 Cr (FY 2024) | 77.0% | Pune, Maharashtra, India | |||
| Rahul X-Ray Private Limited | ₹1.11 Cr (FY 2025) | 19.0% | Burhanpur, Madhya Pradesh, India | |||
| Western Diagnostic Centre Private Limited | ₹1.11 Cr (FY 2025) | -16.0% | Kolkata, West Bengal, India | |||
| Criticare Life Sciences Private Limitedthis company | ₹1.11 Cr (FY 2025) | ₹16.2 Lakh | 14.6% | 6.0% | Thane, Maharashtra, India |
To see the full peer comparison of Criticare Life Sciences Private Limited, buy the company report.
Auditor
Criticare Life Sciences Private Limited is audited by RANJAN NEHAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RANJAN NEHAL & ASSOCIATES | FY 2021 | 151015W |
Shareholding
The shareholding of Criticare Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Criticare Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Criticare Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Criticare Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Criticare Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Criticare Life Sciences Private Limited has 2 board changes on record since 2008: 2 appointments. The latest: Kiran Santosh Rathi was appointed as Director on 06 Aug 2008.
Frequently asked questions
Criticare Life Sciences is an active private limited company based in Thane, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 06 August 2008 (18+ years old) and is registered under CIN U85190MH2008PTC185542.
Criticare Life Sciences has 2 current directors:
- Kiran Santosh Rathi - Director
- Santosh Mohanlal Rathi - Director
The latest financial statements of Criticare Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Criticare Life Sciences is U85190MH2008PTC185542. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Criticare Life Sciences was incorporated on 06 August 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Criticare Life Sciences by revenue are Ajey Diagnostics Private Limited, Rahul X-Ray Private Limited, Western Diagnostic Centre Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (human health activities).
Kiran Santosh Rathi was appointed as Director on 06 Aug 2008. Santosh Mohanlal Rathi was appointed as Director on 06 Aug 2008.
The registered office of Criticare Life Sciences is at Between Hotel Royal Challenge II & CadburyS Ltd Eastern Express HighwayService Road, Thane, Maharashtra, India – 400602.
Criticare Life Sciences operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
The compliance status of Criticare Life Sciences is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.
Criticare Life Sciences can be reached at its registered office: Between Hotel Royal Challenge II & CadburyS Ltd Eastern Express HighwayService Road, Thane, Maharashtra, India – 400602.